Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 110, Issue 10, Pages 2462-2471
Publisher
Springer Nature
Online
2014-04-09
DOI
10.1038/bjc.2014.181
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating microRNAs as potential new biomarkers for prostate cancer
- (2013) A Sita-Lumsden et al. BRITISH JOURNAL OF CANCER
- Phosphoproteomic Profiling Identifies Focal Adhesion Kinase as a Mediator of Docetaxel Resistance in Castrate-Resistant Prostate Cancer
- (2013) B. Y. Lee et al. MOLECULAR CANCER THERAPEUTICS
- Circulating microRNA Profiling Identifies a Subset of Metastatic Prostate Cancer Patients with Evidence of Cancer-Associated Hypoxia
- (2013) Heather H. Cheng et al. PLoS One
- Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205
- (2012) Martin Puhr et al. AMERICAN JOURNAL OF PATHOLOGY
- Changes in circulating microRNA levels associated with prostate cancer
- (2012) R J Bryant et al. BRITISH JOURNAL OF CANCER
- The microcosmos of cancer
- (2012) Amaia Lujambio et al. NATURE
- Comparing the MicroRNA Spectrum between Serum and Plasma
- (2012) Kai Wang et al. PLoS One
- Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer
- (2012) Han Christine Ngoc Nguyen et al. PROSTATE
- MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3
- (2011) Bing Feng et al. CANCER
- MicroRNAs as regulators of epithelial-mesenchymal transition
- (2011) Philip A. Gregory et al. CELL CYCLE
- The microRNA-17~92 cluster: Still a miRacle?
- (2011) Angelika Bonauer et al. CELL CYCLE
- Comparison of Circulating MicroRNA 141 to Circulating Tumor Cells, Lactate Dehydrogenase, and Prostate-Specific Antigen for Determining Treatment Response in Patients With Metastatic Prostate Cancer
- (2011) Jason C. Gonzales et al. Clinical Genitourinary Cancer
- miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy
- (2011) M. Garofalo et al. CURRENT MOLECULAR MEDICINE
- Pathways of chemotherapy resistance in castration-resistant prostate cancer
- (2011) K. L. Mahon et al. ENDOCRINE-RELATED CANCER
- Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
- (2011) T. Shree et al. GENES & DEVELOPMENT
- Identification of endogenous normalizers for serum MicroRNAs by microarray profiling: U6 small nuclear RNA is not a reliable normalizer
- (2011) Ruiqun Qi et al. HEPATOLOGY
- Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization
- (2011) Manav Korpal et al. NATURE MEDICINE
- MicroRNAs in body fluids—the mix of hormones and biomarkers
- (2011) Maria Angelica Cortez et al. Nature Reviews Clinical Oncology
- MicroRNA-mediated drug resistance in breast cancer
- (2011) Kristy R. Kutanzi et al. Clinical Epigenetics
- Normalization strategies for microRNA profiling experiments: a ‘normal’ way to a hidden layer of complexity?
- (2010) Swanhild U. Meyer et al. BIOTECHNOLOGY LETTERS
- Circulating miRNAs are correlated with tumor progression in prostate cancer
- (2010) Jan C. Brase et al. INTERNATIONAL JOURNAL OF CANCER
- Serum miRNA-21: Elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy
- (2010) Hai-Liang Zhang et al. PROSTATE
- miR-21: An Androgen Receptor-Regulated MicroRNA that Promotes Hormone-Dependent and Hormone-Independent Prostate Cancer Growth
- (2009) J. Ribas et al. CANCER RESEARCH
- Identification of Candidate Biomarkers of Therapeutic Response to Docetaxel by Proteomic Profiling
- (2009) L. Zhao et al. CANCER RESEARCH
- Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer
- (2008) S. Ambs et al. CANCER RESEARCH
- miR-21: a small multi-faceted RNA
- (2008) Anna M. Krichevsky et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The Inhibition of the Highly Expressed Mir-221 and Mir-222 Impairs the Growth of Prostate Carcinoma Xenografts in Mice
- (2008) Neri Mercatelli et al. PLoS One
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started